RESPONSIBLE OPIOID PRESCRIBING PRACTICES Final Examination Questions Select the best answer for each question and mark your answers on the Final Examination Answer Sheet found on page 107, or complete your test online at BOOK.CME.EDU 26. Recent statistics report the number of drug overdose deaths in 2021 to be:
32. Benefits of using buprenorphine in the treatment of OUD include: a. Daily evaluation of patients is required for treatment with buprenorphine. b. Low risk for respiratory depression. c. Permission for prescribing is automatically granted for all individuals upon activation of a state medical license. d. It is available only in short acting formulations. 33. What is considered first line treatment of opiate use disorder (OUD) in pregnant females? a. Naloxone. b. Only Buprenorphine. c. Only Methadone. d. Either Buprenorphine or Methadone. 34. Physician practitioners must complete _______________ to be certified to prescribe buprenorphine? a. 4 hours of in-person training. b. 8 hours of virtual training. c. 12 hour of either in-person/virtual training. d. A buprenorphine waiver application though SAMHSA. 35. When administering naloxone to a suspected opioid overdose patient: a. Risk for cardiac complications are high and administration must be delayed until patient is on a cardiac monitor. b. The half-life of naloxone is several hours and frequently outlasts the opioid that caused the overdose side effects. c. Anyone, including family members, can administer intra-nasal (IN) naloxone safely in the context of a suspected opioid overdose. d. Individuals unconscious due to illness NOT related to opioid overdose are risk for severe complications from the unnecessary administration of naloxone.
a. About 10,000. b. About 30,000. c. Almost 70,000. d. Over 100,000. 27. Side effects of opioid medications include all of the following EXCEPT: a. Respiratory Depression. b. Pruritis. c. Constipation. d. Agitation. 28. Opioids have indirect effects on the body that stimulate which physiologic systems? a. Estrogen receptors. b. Pancreatic enzyme secretion. c. Histamine. d. Melanin production. 29. Regarding opioid medication: a. Overdose was 5 times more likely in patients prescribed extended-release opioids compared to immediate-release opioids. b. Opioids are far superior than non-opioid medications in the treatment of all types of pain. c. Chronic pain should be treated primarily with short-acting opioids. d. The risks of developing opioid use disorder occurs only after months of use. 30. This agency within the U.S. Department of Health and Human Services leads public health efforts to advance the behavioral health of the nation and regulates the safe use of medications for the treatment of OUD.
a. DEA. b. CDC. c. SAHMSA. d. Joint Commission. 31. Buprenorphine is an opioid _________. a. Full Agonist. b. Partial Agonist. c. Antagonist. d. Receptor.
Course Code: CT24CME-303
Page 48
Book Code: CT24CME
Powered by FlippingBook